DeutschNewstral
Article
Mmarketwatch.com on 2020-07-13 15:47
CytoDyn's stock falls after hitting roadblock in FDA application for investigational HIV drug
Related news
Rockville company gains FDA clearance for trial of investigational drug applicationthedailyrecord.com
FDA invites comments on Expanded Access to Investigational Drugs guidancejdsupra.com- MSarepta stock plummets 20% after FDA announces changes to investigational drug processmarketwatch.com
First investigational drug to treat Alzheimer’s disease sent to FDA for approvalFOX 8 News Cleveland- China FDA Solicits Comments on Conditional Approvals for New Drugs and Compassionate Use of Investigational Drugsjdsupra.com
- FDA Issues a Final Rule on Biologics License Applications, Investigational New Drug Applications and Master Filesjdsupra.com
- Clinical Trials: FDA Issues Finalized Charging Guidance for Investigational Drug Use jdsupra.com
- Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy studythedailyrecord.com
- DFDA Recalls Brother Sammy’s HIV/AIDS Drugdailyguidenetwork.com
- FDA accepts Coherus’s resubmitted pegfilgrastim biosimilar applicationjdsupra.com
Folic acid prevents birth defects but hits FDA roadblockPhilly.com- MGSK gets FDA approval for HIV drug for childrenmarketwatch.com
Juul files FDA application to keep selling e-cigarettesocregister.com- FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19jdsupra.com
FDA approves Mylan’s new HIV drugtriblive.com
FDA approves HIV treatment from Mylanbizjournals.com- SFDA Approves Monthly Injectable HIV Drug Combostarobserver.com.au
- Mylan submits new drug application to FDAbizjournals.com
- FDA rejects new drug application from Jupiter biotech firmbizjournals.com
- Noveome Biotherapeutics earns FDA designations for new biologic applicationbizjournals.com